Related references
Note: Only part of the references are listed.HER2 aberrations in cancer: Implications for therapy
Min Yan et al.
CANCER TREATMENT REVIEWS (2014)
Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency
Fernando Bellido et al.
EUROPEAN JOURNAL OF CANCER (2014)
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
Eliezer M. Van Allen et al.
NATURE MEDICINE (2014)
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer
Ana M. Gonzalez-Angulo et al.
CANCER (2013)
Genomics-Driven Oncology: Framework for an Emerging Paradigm
Levi A. Garraway
JOURNAL OF CLINICAL ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
ArrayExpress update-trends in database growth and links to data analysis tools
Gabriella Rustici et al.
NUCLEIC ACIDS RESEARCH (2013)
Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value
Yvonne Chekaluk et al.
PLOS ONE (2013)
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
Jaikrit Bhutani et al.
INFECTIOUS AGENTS AND CANCER (2013)
Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease
Ingiridur Skirnisdottir et al.
BMC CANCER (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations
Tao Xie et al.
PLOS ONE (2012)
Copy-Neutral Loss of Heterozygosity at the p53 Locus in Carcinogenesis of Esophageal Squamous Cell Carcinomas Associated with p53 Mutations
Hiroshi Saeki et al.
CLINICAL CANCER RESEARCH (2011)
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
Christine O'Keefe et al.
BLOOD (2010)
Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells
Patrizia Cammareri et al.
CANCER RESEARCH (2010)
Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer
Musaffe Tuna et al.
PLOS ONE (2010)
Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas
Christine S. Walsh et al.
CLINICAL CANCER RESEARCH (2008)
Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype
Elena Serrano et al.
LEUKEMIA & LYMPHOMA (2008)
Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer
Jude Kendall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas:: an immunohistochemical and chromogenic in situ hybridisation analysis
Jorge S. Reis-Filho et al.
MODERN PATHOLOGY (2006)
Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations
M Griffiths et al.
LEUKEMIA (2005)
Multiplexed genotyping with sequence-tagged molecular inversion probes
P Hardenbol et al.
NATURE BIOTECHNOLOGY (2003)
Loss of heterozygosity associated with uniparental disomy in breast carcinoma
SK Murthy et al.
MODERN PATHOLOGY (2002)
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
R Kralovics et al.
EXPERIMENTAL HEMATOLOGY (2002)
Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies
U Lehmann et al.
METHODS (2001)
Share Paper
